Norges Bank Bristol Myers Squibb CO Transaction History

Norges Bank

$655 Billion
Q2 2024

A detailed history of Norges Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Norges Bank holds 32,594,416 shares of BMY stock, worth $1.73 Billion. This represents 0.21% of its overall portfolio holdings.

Number of Shares

32,594,416

Holding current value

$1.73 Billion

% of portfolio

0.21%

48 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $1.31 Billion - $1.73 Billion	32,594,416 New	32,594,416 $1.35 Billion
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $1.47 Billion - $1.76 Billion	30,413,639 New	30,413,639 $1.56 Billion
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $1.38 Billion - $1.54 Billion	-23,861,771 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$63.71 - $70.74 $324 Million - $360 Million	-5,083,448 Reduced 15.6%	27,510,968 $1.76 Billion
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $1.29 Billion - $1.43 Billion	-20,212,646 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$65.71 - $74.53 $1.8 Billion - $2.04 Billion	27,381,076 New	27,381,076 $1.9 Billion
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $1.78 Billion - $2.11 Billion	26,041,644 New	26,041,644 $1.87 Billion
Q3 2022 Nov 13, 2023	BUY	$0.13 - $76.84 $3.1 Million - $1.83 Billion	23,861,771 New	23,861,771 $1.7 Billion
Q2 2022 Aug 14, 2023	BUY	$72.62 - $79.98 $1.47 Billion - $1.62 Billion	20,212,646 New	20,212,646 $1.56 Billion
Q1 2022 May 12, 2023	SELL	$61.48 - $73.72 $428 Million - $513 Million	-6,960,836 Reduced 26.73%	19,080,808 $1.39 Billion
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $1.39 Billion - $1.67 Billion	-22,677,818 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$53.63 - $62.52 $1.22 Billion - $1.42 Billion	22,677,818 New	22,677,818 $1.41 Billion
Q3 2021 Nov 14, 2022	BUY	$59.17 - $69.31 $1.36 Billion - $1.6 Billion	23,050,335 New	23,050,335 $1.36 Billion
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $1.41 Billion - $1.65 Billion	-23,780,855 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$61.91 - $67.42 $1.47 Billion - $1.6 Billion	23,780,855 New	23,780,855 $1.59 Billion
Q2 2021 Aug 10, 2021	SELL	$61.91 - $67.42 $1.55 Billion - $1.69 Billion	-25,113,748 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$59.34 - $66.74 $1.49 Billion - $1.68 Billion	25,113,748 New	25,113,748 $1.59 Billion
Q1 2021 May 07, 2021	SELL	$59.34 - $66.74 $1.45 Billion - $1.63 Billion	-24,467,302 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$57.74 - $65.43 $1.41 Billion - $1.6 Billion	24,467,302 New	24,467,302 $1.52 Billion
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $1.31 Billion - $1.48 Billion	-22,621,555 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$57.43 - $63.64 $1.3 Billion - $1.44 Billion	22,621,555 New	22,621,555 $1.36 Billion
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $1.3 Billion - $1.44 Billion	-22,611,322 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$54.82 - $64.09 $1.24 Billion - $1.45 Billion	22,611,322 New	22,611,322 $1.33 Billion
Q2 2020 Aug 07, 2020	SELL	$54.82 - $64.09 $1.5 Billion - $1.75 Billion	-27,281,913 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$46.4 - $67.43 $1.27 Billion - $1.84 Billion	27,281,913 New	27,281,913 $1.52 Billion
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $1.26 Billion - $1.82 Billion	-27,062,132 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$49.21 - $64.19 $1.33 Billion - $1.74 Billion	27,062,132 New	27,062,132 $1.74 Billion
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $874 Million - $1.14 Billion	-17,765,283 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$42.77 - $50.71 $760 Million - $901 Million	17,765,283 New	17,765,283 $901 Million
Q3 2019 Nov 08, 2019	SELL	$42.77 - $50.71 $734 Million - $870 Million	-17,151,925 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$44.62 - $49.34 $765 Million - $846 Million	17,151,925 New	17,151,925 $778 Million
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $765 Million - $846 Million	-17,139,192 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$45.12 - $53.8 $81.5 Million - $97.1 Million	1,805,624 Added 11.78%	17,139,192 $818 Million
Q4 2018 Mar 04, 2019	BUY	$48.76 - $63.23 $748 Million - $970 Million	15,333,568 New	15,333,568 $797 Million
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $740 Million - $959 Million	-15,173,632 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$55.19 - $62.25 $837 Million - $945 Million	15,173,632 New	15,173,632 $942 Million
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $835 Million - $941 Million	-15,124,231 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$50.53 - $62.98 $764 Million - $953 Million	15,124,231 New	15,124,231 $837 Million
Q2 2018 Jul 23, 2018	SELL	$50.53 - $62.98 $762 Million - $950 Million	-15,076,577 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$59.92 - $68.98 $903 Million - $1.04 Billion	15,076,577 New	15,076,577 $954 Million
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $890 Million - $1.02 Billion	-14,854,823 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$59.94 - $65.35 $890 Million - $971 Million	14,854,823 New	14,854,823 $910 Million
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $890 Million - $971 Million	-14,854,823 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$55.23 - $63.74 $820 Million - $947 Million	14,854,823 New	14,854,823 $947 Million
Q3 2017 Nov 07, 2017	SELL	$55.23 - $63.74 $820 Million - $947 Million	-14,854,823 Closed	0 $0
Q2 2017 Jul 24, 2018	BUY	N/A	580,424 Added 4.07%	14,854,823 $828 Million
Q1 2017 May 11, 2018	BUY	N/A	1,202,351 Added 9.2%	14,274,399 $776 Million
Q3 2016 Nov 13, 2017	BUY	N/A	13,072,048	13,072,048 $0

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account